Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis.

Leukemia & lymphoma - 1 Mar 2014

Zheng Wenli, Medeiros L Jeffrey, Young Ken H, Goswami Maitrayee, Powers Linda, Kantarjian Hagop H, Thomas Deborah A, Cortes Jorge E, Wang Sa A

Abstract excerpt

We assessed CD30 expression in patients with acute lymphoblastic leukemia (ALL) of either T-cell or B-cell lineage to examine the potential benefit of anti-CD30-targeted therapy in this group of patients. Bone marrow specimens of 34 patients with T- and 44 with B-ALL were assessed for CD30 expres...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Antineoplastic Combined Chemotherapy Protocols
Share to Flow Cytometry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunophenotyping

Share to Ki-1 Antigen

Share to Oncogene Proteins, Fusion

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Translocation, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 23937105
DOI: 10.3109/10428194.2013.820293
PMCID: PMC4188389

Genes

ABL1
BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23937105-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis.PMID 23937105Read ↗

CD30 in myeloid malignancies: hitting the bull's-eye with an available dart.Semantic proximity Read ↗

CD30 in Normal and Neoplastic CellsSemantic proximity Read ↗

Clinical implications of serum levels of soluble CD30 in 70 adult anaplastic large-cell lymphoma patients.Semantic proximity Read ↗

Clinical significance of CD34 expression in childhood acute lymphoblastic leukemiaSemantic proximity Read ↗

CD30—Governor of Memory T Cells?Semantic proximity Read ↗

CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometrySemantic proximity Read ↗

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330.Semantic proximity Read ↗

Expression and functional characterization of CD33 transcript variants in human acute myeloid leukemiaSemantic proximity Read ↗

Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.